The University of Southampton
University of Southampton Institutional Repository

DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity

DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity
DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity
In follicular lymphoma (FL), surface immunoglobulin (sIg) carries mandatory N-glycosylation sites in the variable regions, inserted during somatic hypermutation. These glycosylation sites are tumor-specific, indicating a critical function in FL. Added glycan unexpectedly terminates at high mannose (Mann) and confers capability for sIg-mediated interaction with local macrophage-expressed DC-SIGN lectin resulting in low-level activation of upstream B-cell receptor signaling responses. Here we show that despite being of low-level, DC-SIGN induces a similar downstream transcriptional response to anti-IgM in primary FL cells, characterized by activation of pathways associated with B-cell survival, proliferation and cell–cell communication. Lectin binding was also able to engage post-transcriptional receptor cross-talk pathways since, like anti-IgM, DC-SIGN down-modulated cell surface expression of CXCR4. Importantly, pre-exposure of a FL-derived cell line expressing sIgM-Mann or primary FL cells to DC-SIGN, which does not block anti-IgM binding, reversibly paralyzed the subsequent Ca2+ response to anti-IgM. These novel findings indicate that modulation of sIg function occurs in FL via lectin binding to acquired mannoses. The B-cell receptor alternative engagement described here provides two advantages to lymphoma cells: (i) activation of signaling, which, albeit of low-level, is sufficient to trigger canonical lymphoma-promoting responses, and (ii) protection from exogenous antigen by paralyzing anti-IgM-induced signaling. Blockade of this alternative engagement could offer a new therapeutic strategy.
2045-2322
Valle-Argos, Beatriz
4fddaa71-c0aa-4b95-b464-8bdb592428a2
Chiodin, Giorgia
4b3e9525-b377-4d16-b69a-e05d2e7854fe
Bryant, Dean
10ed83e8-8080-4d9c-bba5-df9d4eec3a10
Taylor, Joe
6a4a31d0-defc-4b85-b4bd-1292b356ef51
Lemm, Elizabeth
f363493b-47ce-4f8e-9e94-272486397cb3
Duriez, Patrick
4cf499bc-007a-43b3-b180-d6e5dc3d151b
Rock, Philip J
d679ced0-026b-4876-9c1e-ba89d90e2d5d
Strefford, Jonathan
3782b392-f080-42bf-bdca-8aa5d6ca532f
Forconi, Francesco
ce9ed873-58cf-4876-bf3a-9ba1d163edc8
Burack, Richard
d2d22d87-512a-452b-8360-bc5a3676fcdb
Packham, Graham
fdabe56f-2c58-469c-aadf-38878f233394
Stevenson, Freda
ba803747-c0ac-409f-a9c2-b61fde009f8c
Valle-Argos, Beatriz
4fddaa71-c0aa-4b95-b464-8bdb592428a2
Chiodin, Giorgia
4b3e9525-b377-4d16-b69a-e05d2e7854fe
Bryant, Dean
10ed83e8-8080-4d9c-bba5-df9d4eec3a10
Taylor, Joe
6a4a31d0-defc-4b85-b4bd-1292b356ef51
Lemm, Elizabeth
f363493b-47ce-4f8e-9e94-272486397cb3
Duriez, Patrick
4cf499bc-007a-43b3-b180-d6e5dc3d151b
Rock, Philip J
d679ced0-026b-4876-9c1e-ba89d90e2d5d
Strefford, Jonathan
3782b392-f080-42bf-bdca-8aa5d6ca532f
Forconi, Francesco
ce9ed873-58cf-4876-bf3a-9ba1d163edc8
Burack, Richard
d2d22d87-512a-452b-8360-bc5a3676fcdb
Packham, Graham
fdabe56f-2c58-469c-aadf-38878f233394
Stevenson, Freda
ba803747-c0ac-409f-a9c2-b61fde009f8c

Valle-Argos, Beatriz, Chiodin, Giorgia, Bryant, Dean, Taylor, Joe, Lemm, Elizabeth, Duriez, Patrick, Rock, Philip J, Strefford, Jonathan, Forconi, Francesco, Burack, Richard, Packham, Graham and Stevenson, Freda (2021) DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity. Scientific Reports, 11 (1), [11676]. (doi:10.1038/s41598-021-91112-7).

Record type: Article

Abstract

In follicular lymphoma (FL), surface immunoglobulin (sIg) carries mandatory N-glycosylation sites in the variable regions, inserted during somatic hypermutation. These glycosylation sites are tumor-specific, indicating a critical function in FL. Added glycan unexpectedly terminates at high mannose (Mann) and confers capability for sIg-mediated interaction with local macrophage-expressed DC-SIGN lectin resulting in low-level activation of upstream B-cell receptor signaling responses. Here we show that despite being of low-level, DC-SIGN induces a similar downstream transcriptional response to anti-IgM in primary FL cells, characterized by activation of pathways associated with B-cell survival, proliferation and cell–cell communication. Lectin binding was also able to engage post-transcriptional receptor cross-talk pathways since, like anti-IgM, DC-SIGN down-modulated cell surface expression of CXCR4. Importantly, pre-exposure of a FL-derived cell line expressing sIgM-Mann or primary FL cells to DC-SIGN, which does not block anti-IgM binding, reversibly paralyzed the subsequent Ca2+ response to anti-IgM. These novel findings indicate that modulation of sIg function occurs in FL via lectin binding to acquired mannoses. The B-cell receptor alternative engagement described here provides two advantages to lymphoma cells: (i) activation of signaling, which, albeit of low-level, is sufficient to trigger canonical lymphoma-promoting responses, and (ii) protection from exogenous antigen by paralyzing anti-IgM-induced signaling. Blockade of this alternative engagement could offer a new therapeutic strategy.

This record has no associated files available for download.

More information

Accepted/In Press date: 20 May 2021
Published date: 3 June 2021
Additional Information: Funding Information: The authors thank the patients involved in this study for the kind gift of samples and Dr. Kathy Potter (Tissue Bank, Cancer Sciences, University of Southampton) for processing and storage of FL samples. This work was supported by Grants from Cancer Research UK [C2750/A23669, C42023/A29370, C36811/A29101], the Southampton Experimental Cancer Medicine and Cancer Research Centers [C24563/A15581; C34999/A18087], Worldwide Cancer Research [13-0267] and Bloodwise [18009]. Funding Information: J. Strefford reports receiving commercial research grants from Roche. F. Forconi reports receiving commercial research grants from Gilead sciences. B. Valle-Argos, G. Chiodin, D. J. Bryant, J. Taylor, E. Lemm, P. Duriez, P. J. Rock, R. W. Burack, G. Packham and F. K. Stevenson have no competing interests. Publisher Copyright: © 2021, The Author(s).

Identifiers

Local EPrints ID: 449811
URI: http://eprints.soton.ac.uk/id/eprint/449811
ISSN: 2045-2322
PURE UUID: 20417102-f7ac-41b7-8e3f-5669945f7313
ORCID for Dean Bryant: ORCID iD orcid.org/0000-0003-3163-608X
ORCID for Patrick Duriez: ORCID iD orcid.org/0000-0003-1814-2552
ORCID for Jonathan Strefford: ORCID iD orcid.org/0000-0002-0972-2881
ORCID for Francesco Forconi: ORCID iD orcid.org/0000-0002-2211-1831
ORCID for Graham Packham: ORCID iD orcid.org/0000-0002-9232-5691
ORCID for Freda Stevenson: ORCID iD orcid.org/0000-0002-0933-5021

Catalogue record

Date deposited: 18 Jun 2021 16:30
Last modified: 17 Mar 2024 03:35

Export record

Altmetrics

Contributors

Author: Beatriz Valle-Argos
Author: Giorgia Chiodin
Author: Dean Bryant ORCID iD
Author: Joe Taylor
Author: Elizabeth Lemm
Author: Patrick Duriez ORCID iD
Author: Philip J Rock
Author: Richard Burack
Author: Graham Packham ORCID iD
Author: Freda Stevenson ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×